We are monitoring the impact of COVID-19 on MEA HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2058
Share on
Share on

Middle East & Africa HIV Diagnostics Market Research Report - Segmented By Product, Type, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 2058
Pages: 130

Middle East & Africa HIV Diagnostics Market Size & Growth (2021 to 2026):

As per the research report, the size of the Middle east and Africa HIV Diagnostics Market is valued USD 247.99 million in 2021 and estimated to be growing at a CAGR of 7.82%, to reach 361.35 million by 2026 during the forecast period 2021 to 2026.

DRIVERS:

The MEA market is predicted to develop due to factors such as the rising prevalence of HIV, the rising number of blood transfusions and blood donations, the benefits provided by point-of-care tools and kits, and increased government initiatives. The presence of important companies, the high prevalence of HIV in the region, and developed healthcare infrastructure are some of the key factors contributing to the market's huge share.

The unprecedented efforts of many social organisations to raise awareness about HIV and its symptoms, as well as to encourage people to get regular blood tests, will help the HIV diagnostics market expand. In comparison to the North African region, HIV prevalence in Africa, particularly in the Southern region, is quite high. HIV affects about one out of every four people. The Southern and Eastern African regions have one of the highest HIV prevalence rates, with around 20 million individuals infected. While the prevalence of HIV is low in North Africa, the number of HIV cases is constantly increasing.

When the Middle East and African HIV Diagnosis and Treatment markets are considered, Africa is thought to be the largest market for HIV Diagnosis and Treatment. Furthermore, the Rest of the Middle East and Africa is expanding, and it is now the second largest market for HIV Diagnosis and Treatment in the Middle East and Africa.

RESTRAINTS:

Saudi Arabia's market growth will most likely be limited yet moderate. The lack of nucleic acid test mandates in this nation is a key restriction to market expansion.

This research report on the Middle East & Africa HIV Diagnostics Market has been segmented and sub-segmented into the following categories:

By Product:

  • Consumables
  • Instruments
  • Software
  • Services                

By Type:

  • Antibody Tests
  • Viral Identification Tests
  • CD4 Testing
  • Viral Load testing
  • Early Infant Diagnostics              

By End User:

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End Users             

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

REGIONAL ANALYSIS:

The market is being boosted by the efficacy of antigen testing, an increase in government initiatives and programmes. African chiefs of state, for example, have approved two significant new programmes efforts to eliminate AIDS/HIV by 2030. The Western and Central Africa Catch-up Plan intends to reduce the gap in HIV treatment access between African regions by accelerating access to HIV treatment in the region. Increasing government initiatives to raise knowledge about HIV disease prevention and treatment options.

Initially, HIV prevention efforts primarily focused on changing behaviour to avoid HIV transmission through sexual contact. Chronic diseases have a significant impact on the Middle East and Africa region. The lack of a functioning healthcare system in African countries, as well as a lack of awareness of novel disease diagnosis tools, are the primary causes of this escalating burden. The country with the largest number of HIV-positive people is South Africa.It was seen that NCDs (Non Communicable Diseases) such as heart disease, stroke, cancer, diabetes, and chronic lung disease were on the rise in South Africa.

The African region is expected to have a significant need for diagnostics as a result of the rising burden of chronic diseases, which is a result of a lack of adequate diagnosis. The United Arab Emirates and Saudi Arabia are primarily medical tourism destinations, and as a result, they are the most important locations in the Middle East and Africa region for many industries.

The leading companies leading in the MEA HIV diagnostics Market profiled in the report are Abbott Healthcare, Brsitol-Myers Squibb, Abbvie Inc., Alere Inc., Gilead Sciences, Merck & Co. Inc, Janssen Therapeutics, BD Biosciences, VIIV Healthcare, Partec, Sysmex, Beckman Coulter, Apogee Flow Systems, Zyomyx Inc., PointCare Technologies Inc., Mylan inc., Qiagen, Roche Diagnostics, Siemens Healthcare, and bioMerieux.

1.Introduction        

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions 

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design          

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary 

                3.2 Key Inferences          

                3.3 Epidemology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints     

                4.3 Key Challenges          

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Product         

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

5.1.2.1 Assays and Kits &Reagents                           

5.1.2.2 Other Consumables                        

                                5.1.3 Instruments                                           

                                5.1.4 Software & Services                                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Type    

                                5.2.1 Introduction                                           

                                5.2.2 Antibody Tests                                      

5.2.2.1 HIV Screening Tests                         

      5.2.2.1.1 Elisa    

      5.2.2.1.2 Rapid Tests      

      5.2.2.1.3 Home Access Dried Blood Spots             

5.2.2.2 HIV-1 Antibody Confirmatory Tests                          

      5.2.2.2.1 Western Blot Tests       

      5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)      

      5.2.2.2.3 Line Immunoassays     

      5.2.2.2.4 Radio-Immunoprecipitation Assays      

5.2.2.3  HIV-2 & Group O Diagnostic Tests                            

      5.2.2.3.1 Blood Antibody Tests  

      5.2.2.3.2 DBS Tests         

      5.2.2.3.3 Line ImmunoAssay (HIV2)         

                                5.2.3 Viral Identification Tests                                    

5.2.3.1 p24 Antigen Test                               

5.2.3.2 Qualitative PCR Tests                      

5.2.3.3 Viral Culture                        

                                5.2.4 CD4 Testing                                             

                                5.2.5 Viral Load testing                                  

                                5.2.6 Early Infant Diagnostics                                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 End User       

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostic Laboratories                                     

                                5.3.3 Hospitals                                  

                                5.3.4 Blood Banks                                            

                                5.3.5 Home Care Settings                                            

                                5.3.6 Other End Users                                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                                             

                                5.3.8  Market Attractiveness Analysis, By End User                                          

                                5.3.9  Market Share Analysis, By End User                                            

6. Geographical Analysis                    

                6.1 Introduction     

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Product                           

6.1.3.3 By Type                 

6.1.3.4 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Product                           

6.1.4.3 By Type                 

6.1.4.4 By End User                        

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Product                           

6.1.5.3 By Type                 

6.1.5.4 By End User                        

                6.2 Middle-East      

                6.3 Africa  

7.Strategic Analysis              

                7.1 PESTLE analysis          

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis    

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis               

                8.1 Siemens Healthineers (A Division of Siemens AG)      

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)  

                8.3 Abbott Laboratories     

                8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)   

                8.5 Thermo-Fisher Scientific Inc.     

                8.6 Merck KGaA     

                8.7 Becton, Dickinson & Company

                8.8 Hologic Inc.  

                8.9 Alere Inc.      

                8.10 Bio-Rad Laboratories  

9.Competitive Landscape                  

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                

Appendix                 

                a) List of Tables 

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Million )
  2. Middle East & Africa Consumables Market By Region, From 2021 to 2026 ( USD Million )
  3. Middle East & Africa Instruments Market By Region, From 2021 to 2026 ( USD Million )
  4. Middle East & Africa Software & Services Market By Region, From 2021 to 2026 ( USD Million )
  5. Middle East & Africa HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Million )
  6. Middle East & Africa Antibody Tests Market By Region, From 2021 to 2026 ( USD Million )
  7. Middle East & Africa Viral Identification tests Market By Region, From 2021 to 2026 ( USD Million )
  8. Middle East & Africa CD4 Testing Market By Region, From 2021 to 2026 ( USD Million )
  9. Middle East & Africa Viral Load Testing Market By Region, From 2021 to 2026 ( USD Million )
  10. Middle East & Africa Early Infant Diagnosticss Market By Region, From 2021 to 2026 ( USD Million )
  11. Middle East & Africa HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Million )
  12. Middle East & Africa Diagnostic Labortaries Market By Region, From 2021 to 2026 ( USD Million )
  13. Middle East & Africa Hospitals Market By Region, From 2021 to 2026 ( USD Million )
  14. Middle East & Africa Blood Banks Market By Region, From 2021 to 2026 ( USD Million )
  15. Middle East & Africa Home Care Settings Market By Region, From 2021 to 2026 ( USD Million )
  16. Middle East & Africa Other End Users Market By Region, From 2021 to 2026 ( USD Million )
  17. Middle East HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Million )
  18. Middle East HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Million )
  19. Middle East HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Million )
  20. Africa HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Million )
  21. Africa HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Million )
  22. Africa HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample